NCT07715734 clinical trial report covering Cetuximab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07715097 clinical trial report covering Targeting Survivin DC Cells (Tricision), Phase 2, endpoints, sponsor, geography, readout timing and development whi

NCT07714369 clinical trial report covering Zavegepant, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07715396 clinical trial report covering Tislelizumab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07714447 clinical trial report covering ARM-002TM, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07715318 clinical trial report covering Spironolactone, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07714551 clinical trial report covering Zanzalintinib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07712926 clinical trial report covering Tetravalent dengue virus vaccine(Instituto Butantan), Phase 3, endpoints, sponsor, geography, readout timing and de

NCT07714616 clinical trial report covering Cyproterone Acetate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

SillaJen 2026 BD opportunity scan: pipeline assets, transaction precedents, financial signals, IP-risk flags, and a prioritized partnering shortlist.

Genexine 2026 BD opportunity scan: pipeline assets, transaction precedents, financial signals, IP-risk flags, and a prioritized partnering shortlist.

Ractigen Therapeutics 2026 BD opportunity scan: pipeline assets, transaction precedents, financial signals, IP-risk flags, and a prioritized partnering shortlist.